Press Releases
Back to Previous Page
 


News Release
October 10, 2013
Contact: Karen Hall
Phone: +1 978-715-1567
Email: karen.hall@emdmillipore.com

Beijing Higher Court Rules in Favor of EMD Millipore in Patent Infringement Case

October 10, 2013, Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, today announced that the Beijing Higher Court, Beijing, China has affirmed a lower court’s decision against RephiLe Bioscience for copying and selling purification cartridges for lab water systems, infringing on patents owned by EMD Millipore. The Court determined that RephiLe’s accused products fall into the protection scope of EMD Millipore’s patent. The decision upholds the permanent injunction against RephiLe to discontinue making, selling and offering to sell the infringing products. The decision also confirmed the award of damages to EMD Millipore originally set by the lower court.

“We are pleased by the judgment rendered in this case,” noted Bernard Arend, VP of EMD Millipore’s Lab Water Business. “It is a very positive indicator that Chinese authorities and the Chinese legal system recognize the importance of intellectual property rights for both foreign companies trading in the country and Chinese domestic companies trading globally. We invest tens of millions of dollars in research every year to create a portfolio of products superior to and differentiated from our competitors. In addition we invest a significant amount of money to patent many of the inventions incorporated into those products. We will continue to actively protect our patents.”

EMD Millipore reserves the right to take action against any distributors of RephiLe products in any part of the world that continue to supply the infringing products covered by this judgment to the extent allowed by law.

About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA, Darmstadt, Germany, offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of €2.6 billion.